M E DeBakey|J U Gutterman - JoVE Visualize

Showing results (81-90 of 366) with videos related to

Pageof 37

Sort By:

Cancer|October 1, 1991

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.

Blood|January 15, 1990

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinomaJ R Quesada, A Rios, D Swanson, et al.

The EMBO Journal|October 15, 1996

Inhibition of E2F-mediated transcription by p202D Choubey, S J Li, B Datta, et al.

Hematologic Pathology|January 1, 1988

Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.

Journal of the National Cancer Institute|May 1, 1977

The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancerR D Rossen, M A Reisberg, E M Hersh, et al.

Annals of the New York Academy of Sciences|January 1, 1976

In vitro and in vivo studies with thymosin in cancer patientsL A Schafer, A L Goldstein, J U Gutterman, et al.

Journal of the National Cancer Institute|May 1, 1976

Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pigM G Hanna, L C Peters, J U Gutterman, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986

Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.

Surgery|December 1, 1980

Long-term results of treatment of the totally occluded renal artery in forty patients with renovascular hypertensionG M Lawrie, G C Morris, M E DeBakey

Pageof 37

Showing results (81-90 of 366) with videos related to

Sort By:

Pageof 37

Cancer|October 1, 1991

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.

Blood|January 15, 1990

Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinomaJ R Quesada, A Rios, D Swanson, et al.

The EMBO Journal|October 15, 1996

Inhibition of E2F-mediated transcription by p202D Choubey, S J Li, B Datta, et al.

Hematologic Pathology|January 1, 1988

Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.

Journal of the National Cancer Institute|May 1, 1977

The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancerR D Rossen, M A Reisberg, E M Hersh, et al.

Annals of the New York Academy of Sciences|January 1, 1976

In vitro and in vivo studies with thymosin in cancer patientsL A Schafer, A L Goldstein, J U Gutterman, et al.

Journal of the National Cancer Institute|May 1, 1976

Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pigM G Hanna, L C Peters, J U Gutterman, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986

Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.

Surgery|December 1, 1980

Long-term results of treatment of the totally occluded renal artery in forty patients with renovascular hypertensionG M Lawrie, G C Morris, M E DeBakey

Pageof 37